76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI first-line therapy Molecular responses continue to deepen with extended…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm…
WORLD FEDERATION OF DIRECT SELLING ASSOCIATIONS RELEASES ANNUAL DEFINITITVE DATA ON GLOBAL INDUSTRY SHOWING SIGNS OF STABILIZATIONWASHINGTON, Dec. 4, 2025…
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…
DUBAI, UAE, Sept. 17, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has released its Q3 2025…
JOHANNESBURG, Aug. 21, 2025 /PRNewswire/ -- On August 20, two Chery TIGGO9 flagship SUVs performed a 50% offset frontal collision test…
July 22, 2025 02:00 ET | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…
WARSAW, Poland, July 14, 2025 /PRNewswire/ -- At Crypto Expo Dubai 2025, HeraldEX launched two of its highly awaited tools:…
PORT VILA, Vanuatu, July 4, 2025 /PRNewswire/ -- Vantage Markets wrapped up a highly successful showing at Money Expo Colombia…